萬國法律事務所

The Executive Yuan enacted the Statute for Biotechnology & New Medicine Industry Development on July 4, 2007 to promote the biotechnology sector through measures including but not limited to:

1) Building three biotech industrial parks in Nangang, Hsinchu and Kaohsiung;

2) Establishing a US$1 billion biotech development firm to attract international talent;

3) Allocating US$606 million from the National Development Fund for biotech R&D and manufacturing; and

4) Contributing US$909 million to a biotech venture capital fund.

Firms in the biotech sector will be able to enjoy investment tax credits of up to 35% for outlays in R&D and personnel development once the current Statute for Industrial Upgrading is retired at the end of 2009.  Up to 20% of the cost of purchasing shares in a biotech company may be tax deductible after four years of investment. 

Major beneficiaries of the new statute will be R&D-oriented biotech companies whose overseas counterparts or suppliers will be able to invest in technology tax-free.